Alison Potts Bleakman

Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasis

Caitriona Ryan, Alan Menter, Lyn Guenther et al. · British Journal of Dermatology · 2018 · 117 citations · Full text

Ixekizumab Improved Patient-Reported Genital Psoriasis Symptoms and Impact of Symptoms on Sexual Activity vs Placebo in a Randomized, Double-Blind Study

Gil Yosipovitch, Peter Foley, Caitriona Ryan et al. · The Journal of Sexual Medicine · 2018 · 48 citations · Full text

Gynecology, Dermatology, Genps Symptoms +16

The Communicating Needs and Features of IBD Experiences (CONFIDE) Study: US and European Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Ulcerative Colitis

Simon Travis, Alison Potts Bleakman, Marla C. Dubinsky et al. · Inflammatory Bowel Diseases · 2023 · 41 citations · Full text

The Development of a Patient-Reported Outcome Measure for Assessment of Genital Psoriasis Symptoms: The Genital Psoriasis Symptoms Scale (GPSS)

Alice B. Gottlieb, Brian Kirby, Caitriona Ryan et al. · Dermatology and Therapy · 2017 · 36 citations · Full text

Ixekizumab Results in Persistent Clinical Improvement in Moderate-to-Severe Genital Psoriasis During a 52 Week, Randomized, Placebo-Controlled, Phase 3 Clinical Trial

Lyn Guenther, Alison Potts Bleakman, Jamie Weisman et al. · Acta Dermato Venereologica · 2019 · 36 citations · Full text

Genital Psoriasis, Week 52, Persistent Improvements +9